priyank shukla
Personalised Medicine Centre, School of Medicine, Ulster University
Londonderry, United Kingdom
Review Editor
Vaccines and Molecular Therapeutics
Personalised Medicine Centre, School of Medicine, Ulster University
Londonderry, United Kingdom
Review Editor
Vaccines and Molecular Therapeutics
INSERM U1135 Centre d'Immunologie et de Maladies Infectieuses
Paris, France
Review Editor
Vaccines and Molecular Therapeutics
Chonnam National University Medical School
Gwangju, Republic of Korea
Review Editor
Vaccines and Molecular Therapeutics
The Johns Hopkins Hospital, Johns Hopkins Medicine
Baltimore, United States
Review Editor
Vaccines and Molecular Therapeutics
Cincinnati Children's Hospital Medical Center
Cincinnati, United States
Review Editor
Vaccines and Molecular Therapeutics
Saveetha University
Chennai, India
Review Editor
Vaccines and Molecular Therapeutics
University of Genoa
Genoa, Italy
Review Editor
Vaccines and Molecular Therapeutics
University of Colorado Denver
Denver, United States
Review Editor
Vaccines and Molecular Therapeutics
International Center for Cell Therapy & Cancer Immunotherapy (CTCI)
Tel Aviv, Israel
Review Editor
Vaccines and Molecular Therapeutics
Université libre de Bruxelles
Brussels, Belgium
Review Editor
Vaccines and Molecular Therapeutics
University of Antwerp
Antwerp, Belgium
Review Editor
Vaccines and Molecular Therapeutics
Centre National de la Recherche Scientifique (CNRS)
Paris, France
Review Editor
Vaccines and Molecular Therapeutics
National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation
Moscow, Russia
Review Editor
Vaccines and Molecular Therapeutics
Centre for Molecular Biology Severo Ochoa, Spanish National Research Council (CSIC)
Madrid, Spain
Review Editor
Vaccines and Molecular Therapeutics
Virtuvax
Odijk, Netherlands
Review Editor
Vaccines and Molecular Therapeutics
GlaxoSmithKline (Italy)
Siena, Italy
Review Editor
Vaccines and Molecular Therapeutics